AT372076B - Verfahren zur herstellung von neuen peptidyl-arginin-aldehyd-derivaten sowie von salzen dieser verbindungen - Google Patents

Verfahren zur herstellung von neuen peptidyl-arginin-aldehyd-derivaten sowie von salzen dieser verbindungen

Info

Publication number
AT372076B
AT372076B AT0001280A AT1280A AT372076B AT 372076 B AT372076 B AT 372076B AT 0001280 A AT0001280 A AT 0001280A AT 1280 A AT1280 A AT 1280A AT 372076 B AT372076 B AT 372076B
Authority
AT
Austria
Prior art keywords
salts
compounds
producing new
aldehyde derivatives
arginine aldehyde
Prior art date
Application number
AT0001280A
Other languages
English (en)
Other versions
ATA1280A (de
Inventor
Sandor Dr Bajusz
Erzsebet Szell
Eva Dr Barabas
Daniel Dr Bagdy
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of ATA1280A publication Critical patent/ATA1280A/de
Application granted granted Critical
Publication of AT372076B publication Critical patent/AT372076B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0812Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT0001280A 1979-01-04 1980-01-02 Verfahren zur herstellung von neuen peptidyl-arginin-aldehyd-derivaten sowie von salzen dieser verbindungen AT372076B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU79GO1435A HU177098B (en) 1979-01-04 1979-01-04 Process for producing new peptidyl-n-carboxy-l-arginin-a

Publications (2)

Publication Number Publication Date
ATA1280A ATA1280A (de) 1983-01-15
AT372076B true AT372076B (de) 1983-08-25

Family

ID=10996883

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0001280A AT372076B (de) 1979-01-04 1980-01-02 Verfahren zur herstellung von neuen peptidyl-arginin-aldehyd-derivaten sowie von salzen dieser verbindungen

Country Status (20)

Country Link
US (1) US4316889A (de)
JP (1) JPS5951936B2 (de)
AT (1) AT372076B (de)
AU (1) AU533343B2 (de)
BE (1) BE880844A (de)
CA (1) CA1133897A (de)
CH (1) CH643820A5 (de)
DE (1) DE3000225A1 (de)
DK (1) DK149895C (de)
ES (1) ES487464A0 (de)
FI (1) FI67539C (de)
FR (1) FR2445826A1 (de)
HU (1) HU177098B (de)
IL (1) IL58978A (de)
IT (1) IT1166917B (de)
NL (1) NL191537C (de)
NO (1) NO151085C (de)
SE (1) SE448461B (de)
SU (1) SU1366062A3 (de)
ZA (1) ZA796895B (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU178398B (en) * 1979-06-12 1982-04-28 Gyogyszerkutato Intezet Process for producing new agmatine derivatives of activity against haemagglutination
JPS5754157A (en) * 1980-09-19 1982-03-31 Nippon Kayaku Co Ltd L-argininal derivative and its preparation
HU184368B (en) 1981-01-13 1984-08-28 Gyogyszerkutato Intezet Process for preparing d-phenyl-alanyl-l-propyl-l-arginine-ald ehyde-shulphate
EP0124317B1 (de) * 1983-04-27 1990-04-11 Ici Americas Inc. Prolin-Derivate
HU192646B (en) * 1984-12-21 1987-06-29 Gyogyszerkutato Intezet Process for preparing new n-alkyl-peptide aldehydes
JPH0312905Y2 (de) * 1984-12-21 1991-03-26
JPH0536046Y2 (de) * 1987-09-09 1993-09-13
ZA897514B (en) * 1988-10-07 1990-06-27 Merrell Dow Pharma Novel peptidase inhibitors
US5736520A (en) * 1988-10-07 1998-04-07 Merrell Pharmaceuticals Inc. Peptidase inhibitors
JPH0277227U (de) * 1988-11-30 1990-06-13
US5430023A (en) * 1990-09-28 1995-07-04 Eli Lilly And Company Tripeptide antithrombotic agents
CA2075154A1 (en) * 1991-08-06 1993-02-07 Neelakantan Balasubramanian Peptide aldehydes as antithrombotic agents
US5252566A (en) * 1991-11-12 1993-10-12 Eli Lilly And Company Antithrombotic agents
US5416093A (en) * 1991-11-12 1995-05-16 Eli Lilly And Company Antithrombotic agents
US5760235A (en) * 1992-03-04 1998-06-02 Gyogyszerkutato Intezet Kft. Anticoagulant peptide derivatives and pharmaceutical compositions containing the same as well as a process for preparation thereof
US5583146A (en) * 1992-12-02 1996-12-10 Bristol-Myers Squibb Company Heterocyclic thrombin inhibitors
AU675981B2 (en) * 1992-12-02 1997-02-27 Bristol-Myers Squibb Company Guanidinyl-substituted heterocyclic thrombin inhibitors
IL108031A0 (en) * 1992-12-22 1994-04-12 Procter & Gamble Difluoro pentapeptide derivatives and pharmaceutical compositions containing them
US5488037A (en) * 1994-03-04 1996-01-30 Eli Lilly And Company Antithrombotic agents
ZA951618B (en) * 1994-03-04 1996-08-27 Lilly Co Eli Antithrombotic agents
US5602101A (en) * 1994-03-04 1997-02-11 Eli Lilly And Company Antithrombotic agents
US5707966A (en) * 1994-03-04 1998-01-13 Eli Lilly And Company Antithrombotic agents
US5885967A (en) * 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents
US5439888A (en) * 1994-03-04 1995-08-08 Eli Lilly And Company Antithrombotic agents
CA2143533A1 (en) * 1994-03-04 1995-09-05 Kenneth D. Kurz Antithrombotic agents
US5726159A (en) * 1994-03-04 1998-03-10 Eli Lilly And Company Antithrombotic agents
US5436229A (en) * 1994-03-04 1995-07-25 Eli Lilly And Company Bisulfite adducts of arginine aldehydes
US5705487A (en) * 1994-03-04 1998-01-06 Eli Lilly And Company Antithrombotic agents
US5484772A (en) * 1994-03-04 1996-01-16 Eli Lilly And Company Antithrombotic agents
EP0790982B1 (de) * 1994-06-17 2002-02-27 Corvas International, Inc. Verfahren zur herstellung von peptidyl-argininaldehyden
US5514777A (en) * 1994-06-17 1996-05-07 Corvas International, Inc. Methods of synthesis of peptidyl argininals
US5637599A (en) * 1994-06-17 1997-06-10 Corvas International, Inc. Arginine mimic derivatives as enzyme inhibitors
US5710130A (en) * 1995-02-27 1998-01-20 Eli Lilly And Company Antithrombotic agents
US5914319A (en) * 1995-02-27 1999-06-22 Eli Lilly And Company Antithrombotic agents
US5721214A (en) * 1995-06-07 1998-02-24 Cor Therapeutics, Inc. Inhibitors of factor Xa
US5919765A (en) * 1995-06-07 1999-07-06 Cor Therapeutics, Inc. Inhibitors of factor XA
US6046169A (en) * 1995-06-07 2000-04-04 Cor Therapeutics, Inc. Inhibitors of factor XA
US6022861A (en) * 1995-06-07 2000-02-08 Cor Therapeutics, Inc. Ketoheterocyclic inhibitors of factor Xa
US6069130A (en) 1995-06-07 2000-05-30 Cor Therapeutics, Inc. Ketoheterocyclic inhibitors of factor Xa
PL327986A1 (en) 1995-12-29 1999-01-04 Dimensional Pharmaceuticals 3 Amidinic inhibitors of proteases
US6245743B1 (en) 1996-06-05 2001-06-12 Cor Therapeutics, Inc. Inhibitors of factor Xa

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4941418A (de) * 1972-08-29 1974-04-18
HU169870B (de) * 1974-06-14 1977-02-28

Also Published As

Publication number Publication date
AU533343B2 (en) 1983-11-17
DK3880A (da) 1980-07-05
IT1166917B (it) 1987-05-06
CA1133897A (en) 1982-10-19
DK149895B (da) 1986-10-20
IL58978A (en) 1982-09-30
ES8100252A1 (es) 1980-11-01
IT7928304A0 (it) 1979-12-21
SE448461B (sv) 1987-02-23
NO794327L (no) 1980-07-07
NO151085B (no) 1984-10-29
HU177098B (en) 1981-07-28
FI67539B (fi) 1984-12-31
AU5420779A (en) 1980-07-10
NL191537C (nl) 1995-09-04
JPS55122749A (en) 1980-09-20
NL191537B (nl) 1995-05-01
DE3000225C2 (de) 1989-10-19
FR2445826A1 (fr) 1980-08-01
ES487464A0 (es) 1980-11-01
ZA796895B (en) 1980-12-31
DK149895C (da) 1987-04-21
FI800008A (fi) 1980-07-05
ATA1280A (de) 1983-01-15
CH643820A5 (de) 1984-06-29
FI67539C (fi) 1985-04-10
JPS5951936B2 (ja) 1984-12-17
NO151085C (no) 1985-02-06
FR2445826B1 (de) 1984-11-23
SE8000032L (sv) 1980-07-05
US4316889A (en) 1982-02-23
BE880844A (fr) 1980-06-24
NL8000040A (nl) 1980-07-08
DE3000225A1 (de) 1980-07-24
IL58978A0 (en) 1980-03-31
SU1366062A3 (ru) 1988-01-07

Similar Documents

Publication Publication Date Title
AT372076B (de) Verfahren zur herstellung von neuen peptidyl-arginin-aldehyd-derivaten sowie von salzen dieser verbindungen
AT359488B (de) Verfahren zur herstellung von neuen phthalan- -derivaten und ihren pharmazeutisch annehm- baren saeureadditionssalzen
AT358035B (de) Verfahren zur herstellung von neuen indolizin- derivaten und von ihren saeureadditionssalzen
AT361464B (de) Verfahren zur herstellung von neuen derivaten von perhydro-aza-heterocyclen und ihren saeure- additionssalzen
AT354436B (de) Verfahren zur herstellung von neuem 2-brom-6- fluor-n-2-imidazolidinyliden-benzamin und dessen saeureadditionssalzen
AT356110B (de) Verfahren zur herstellung von neuen benzyliso- chinolinderivaten und ihren saeureadditions- salzen
ATA782177A (de) Verfahren zur herstellung von neuen cis-4a-aryloctahydro-1h-2-pyrindin-verbindungen sowie der ungiftigen pharmazeutisch annehmbaren saeuread- ditionssalze davon
AT356814B (de) Verfahren zur herstellung von neuen clavulan- saeurederivaten
AT362367B (de) Verfahren zur herstellung von neuen 1,2,4-oxa- diazolderivaten sowie von salzen dieser ver- bindungen
ATA758877A (de) Verfahren zur herstellung von neuen clavulan- saeurederivaten
AT359076B (de) Verfahren zur herstellung neuer 3-pyrazol-1-yl- pyridazin-derivate und der physiologisch ver- traeglichen saeureadditionssalze dieser ver- bindungen
AT358202B (de) Verfahren zur herstellung von neuen derivaten des 9-chlorprednisolons
AT375080B (de) Verfahren zur herstellung von neuen bromierten 14-oxo-15-hydroxy-e-homoeburnanderivaten und ihren saeureadditionssalzen
AT357535B (de) Verfahren zur herstellung von neuen 4-amino- transdecahydrochinolinderivaten und ihren saeureadditionssalzen
AT386203B (de) Verfahren zur herstellung von neuen apovincaminol-derivaten und ihren saeureadditionssalzen
AT364847B (de) Verfahren zur herstellung von neuen clavulansaeurederivaten
AT350555B (de) Verfahren zur herstellung von neuen additions- salzen von thiazol-5-methanolderivaten
ATA162476A (de) Verfahren zur herstellung von neuen phenoxy- phenylbuttersaeure-derivaten sowie von ihren salzen
ATA86779A (de) Verfahren zur herstellung von neuen cis-4a-phenyl -isochinolin-derivaten und ihren saeureadditionssalzen
AT344713B (de) Verfahren zur herstellung von neuen morpholinderivaten und ihren saeureadditionssalzen
AT376673B (de) Verfahren zur herstellung von neuen piperazinylbenzoheterozyklischen verbindungen und ihren pharmazeutisch annehmbaren salzen
AT371806B (de) Verfahren zur herstellung von 3-n-pyrrolobenzoe- saeurederivaten und salzen davon
AT360675B (de) Verfahren zur herstellung von neuen tetradecapeptiden und ihren pharmazeutisch annehmbaren nichttoxischen saeureadditionssalzen
AT373875B (de) Verfahren zur herstellung von neuen derivaten von perhydro-aza-heterocyclen und ihren saeureadditionssalzen
ATA398778A (de) Verfahren zur herstellung von neuen 2acetoxybenzoesaeureestern von 4-alkyl-3,5-dioxopyrazolidinderivaten und ihren saeureadditionsalzen

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee